Skip to main content
Equibles

Michael W. Kalb

CFO

Catalyst Pharmaceuticals, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael W. Kalb

Michael W. Kalb is recorded as CFO at Catalyst Pharmaceuticals, Inc.. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed December 7, 2023 that Michael W. Kalb was appointed Executive Vice President and CFO, effective January 1, 2024.

“On December 4, 2023, the Company announced the appointment of Michael W. Kalb as the Company’s Executive Vice President and CFO, effective January 1, 2024.”
Catalyst Pharmaceuticals, Inc. Form 8-K, filed December 7, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Catalyst Pharmaceuticals, Inc.

    CFO

    Proxy statement

    Current

    2024-01-01–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Catalyst Pharmaceuticals, Inc.

Current role

CFO

2024-01-01–present

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.